Editas Medicine

300 Third Street, First Floor

Cambridge, MA  02142

Tel: 617.401.9000


Leadership:
Katrine Bosley
CEO


Website:
www.editasmedicine.com


Information:
info@editasmed.com

Editas Medicine

Flagship Partners:  Doug Cole
Initial Investment: 
2013
Status: 
Private

Editas is a leading genome editing company and part of a transformational new area of health care – genomic medicine. The company was founded by the pioneers and world leaders in genome editing bringing specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases.

Doug Cole is on the Board of Directors.